Related Experiment Video
Updated: Apr 6, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
[Multidrug-resistant tuberculosis: epidemiology and risk factors]
S Smaoui Fourati1, H Mzid1, C Marouane1
1Laboratoire régional d'hygiène, CHU Hedi Chaker, route el ain km 4.5 chez Habib djmal tabac, 3042 Sfax, Tunisie; Faculté de pharmacie, Monastir, Tunisie.
Revue De Pneumologie Clinique
|July 27, 2015
Summary
Tuberculosis remains a major global health threat, complicated by drug-resistant strains. Poor treatment adherence is a key risk factor for multidrug-resistant tuberculosis (MDR-TB), necessitating preventive strategies.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Context:
- Tuberculosis (TB) continues to cause significant morbidity and mortality worldwide.
- The rise of multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains complicates TB control efforts.
- Understanding risk factors for MDR-TB is crucial for effective management and prevention.
Purpose:
- To identify and analyze the primary risk factors contributing to the emergence of multidrug-resistant tuberculosis (MDR-TB) strains.
- To inform the development of targeted preventive strategies for MDR-TB control.
Summary:
- Irregular previous tuberculosis treatment with poor adherence is identified as the principal risk factor for developing MDR-TB.
- Other contributing factors include digestive issues, age, sex, and immunosuppression.
- In Tunisia, MDR-TB prevalence is low (0.8% new cases, 12% retreatment), emphasizing the need for preventive measures.
Impact:
- Highlights the critical role of patient adherence in TB treatment to prevent drug resistance.
- Provides data to support localized, preventive TB control strategies.
- Contributes to the global understanding of MDR-TB emergence and management.
Related Concept Videos
01:29Pulmonary Tuberculosis I
1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
01:28Pulmonary Tuberculosis V
888
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
888
01:28Pulmonary Tuberculosis II
2.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.2K
01:26Pulmonary Tuberculosis IV
728
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
728
01:31Pulmonary Tuberculosis III
1.5K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
01:25Mechanism of Antibiotic Resistance in MRSA
115
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
115